Thursday, July 30

Browsing: ART6043Olaparib

Support

FDA Grants Fast Track Designation to ART6043/Olaparib in BRCA-Mutated, HER2– Breast Cancer

By NewsCancerFebruary 25, 20260

The FDA has granted fast track designation to ART6043 plus olaparib (Lynparza) for patients with germline BRCA-mutated HER2-negative locally advanced…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Browsing: ART6043Olaparib

FDA Grants Fast Track Designation to ART6043/Olaparib in BRCA-Mutated, HER2– Breast Cancer

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Latest Post

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Subscribe to Updates

What's Hot

Browsing: ART6043Olaparib